• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SENSEONICS INC. EVERSENSE SENSOR; EVERSENSE CONTINUOUS GLUCOSE MONITOR SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SENSEONICS INC. EVERSENSE SENSOR; EVERSENSE CONTINUOUS GLUCOSE MONITOR SYSTEM Back to Search Results
Model Number 101368-67A
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Skin Discoloration (2074)
Event Date 10/15/2019
Event Type  Injury  
Manufacturer Narrative
This report is being submitted retrospectively as part of an internal review.Potential for development of skin discoloration at the sensor insertion site is a known and anticipated potential adverse effect.The manufacturer reviewed the certificate of conformance for the lot associated with this sensor and was concluded that the lot met the sterilization requirements.The risks identified for the eversense¿ cgm system are common to all cgm systems even though a minor surgical procedure is required for insertion and removal of the sensor.These include local infection, pain or discomfort, inflammation, bleeding at the insertion or removal site, bruising, itching, scarring or skin discoloration, hematoma, erythema, adhesive tape irritation and sensor fracture.Potential for development of skin discoloration at the sensor insertion site is a known and anticipated potential adverse effect.Sensor was removed from the patient to resolve the issue.Furthermore, the manufacturer reviewed the certificate of conformance for the lot associated with this sensor and was concluded that the lot met the sterilization requirements.No remedial action/corrective action/preventive action/field safety corrective action is required.
 
Event Description
Senseonics was made aware of an instance where the patient experienced skin discoloration of the skin in the area of the insertion.She went to the doctor and the sensor was removed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVERSENSE SENSOR
Type of Device
EVERSENSE CONTINUOUS GLUCOSE MONITOR SYSTEM
Manufacturer (Section D)
SENSEONICS INC.
20451 seneca meadows parkway
germantown MD 20876 7005
Manufacturer (Section G)
SENSEONICS INC.
20451 seneca meadows parkway
germantown MD 20876 7005
Manufacturer Contact
vallikannu somasundaram
20451 seneca meadows parkway
germantown, MD 20876-7005
MDR Report Key18278844
MDR Text Key329887276
Report Number3009862700-2023-00411
Device Sequence Number1
Product Code QCD
Combination Product (y/n)Y
Reporter Country CodeIT
PMA/PMN Number
P160048
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Other
Type of Report Initial
Report Date 12/06/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date07/25/2019
Device Model Number101368-67A
Device Lot NumberWP04600
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 01/26/2020
Initial Date FDA Received12/06/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured08/24/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-